JP2016513724A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016513724A5 JP2016513724A5 JP2016502709A JP2016502709A JP2016513724A5 JP 2016513724 A5 JP2016513724 A5 JP 2016513724A5 JP 2016502709 A JP2016502709 A JP 2016502709A JP 2016502709 A JP2016502709 A JP 2016502709A JP 2016513724 A5 JP2016513724 A5 JP 2016513724A5
- Authority
- JP
- Japan
- Prior art keywords
- matrix
- particle size
- dosage form
- drug
- microns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361791726P | 2013-03-15 | 2013-03-15 | |
| US61/791,726 | 2013-03-15 | ||
| PCT/US2014/028125 WO2014143935A1 (en) | 2013-03-15 | 2014-03-14 | Rapidly dispersible dosage form of oxcarbazepine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018172088A Division JP2019006812A (ja) | 2013-03-15 | 2018-09-14 | オキシカルバゼピンの急速分散性の剤形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016513724A JP2016513724A (ja) | 2016-05-16 |
| JP2016513724A5 true JP2016513724A5 (enExample) | 2017-04-06 |
| JP6463333B2 JP6463333B2 (ja) | 2019-01-30 |
Family
ID=51537567
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502709A Active JP6463333B2 (ja) | 2013-03-15 | 2014-03-14 | オキシカルバゼピンの急速分散性の剤形 |
| JP2018172088A Abandoned JP2019006812A (ja) | 2013-03-15 | 2018-09-14 | オキシカルバゼピンの急速分散性の剤形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018172088A Abandoned JP2019006812A (ja) | 2013-03-15 | 2018-09-14 | オキシカルバゼピンの急速分散性の剤形 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9314429B2 (enExample) |
| EP (1) | EP2968354B1 (enExample) |
| JP (2) | JP6463333B2 (enExample) |
| CN (1) | CN105050604B (enExample) |
| AU (2) | AU2014228063B2 (enExample) |
| CA (1) | CA2906107C (enExample) |
| ES (1) | ES2761265T3 (enExample) |
| HK (1) | HK1213472A1 (enExample) |
| MX (1) | MX364381B (enExample) |
| WO (1) | WO2014143935A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
| AU2014228990B2 (en) | 2013-03-15 | 2017-02-02 | Aprecia Pharmaceuticals LLC | Rapid disperse dosage form containing levetiracetam |
| US10716648B2 (en) * | 2014-05-02 | 2020-07-21 | University Of Louisville Research Foundation, Inc. | Methods for fabricating dental restorations |
| EP4512394A3 (en) | 2015-06-03 | 2025-10-22 | Triastek, Inc. | Dosage forms and use thereof |
| CN105770899A (zh) * | 2016-03-07 | 2016-07-20 | 北京诺康达医药科技有限公司 | 一种大剂量药物的速释制剂及其制备方法 |
| AU2017235598A1 (en) * | 2016-03-18 | 2018-08-09 | Grünenthal GmbH | Floating pharmaceutical dosage form |
| US10765658B2 (en) | 2016-06-22 | 2020-09-08 | Mastix LLC | Oral compositions delivering therapeutically effective amounts of cannabinoids |
| GB201612853D0 (en) | 2016-07-25 | 2016-09-07 | Univ Central Lancashire | Solid dosage form production |
| CA3051614A1 (en) | 2017-01-26 | 2018-08-02 | Triastek, Inc. | Dosage forms of controlled release at specific gastrointestinal sites |
| US10703549B2 (en) * | 2017-06-30 | 2020-07-07 | The Procter And Gamble Company | Water soluble containers and methods of making them |
| WO2019081540A1 (en) * | 2017-10-26 | 2019-05-02 | Merck Patent Gmbh | METHODS FOR ACHIEVING CELL CULTURE |
| US11571391B2 (en) | 2018-01-09 | 2023-02-07 | Triastek, Inc. | Oral drug dosage forms compromising a fixed-dose of an ADHD non-stimulant and an ADHD stimulant |
| US12544446B2 (en) | 2018-03-02 | 2026-02-10 | Vitiprints, LLC | Printed delivery device having supplements |
| EP3866757B1 (en) | 2018-10-15 | 2022-08-10 | Aprecia Pharmaceuticals LLC | Method and system for forming a dosage form within a packaging |
| EP3662898A1 (en) * | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Solid composition comprising mesalazine |
| CA3126903A1 (en) | 2019-01-18 | 2020-07-23 | Ihi Corporation | Thrust foil bearing |
| EP3789015A1 (en) * | 2019-09-05 | 2021-03-10 | Universität Innsbruck | Fast consolidating compounds |
| ES2828509B2 (es) | 2019-11-26 | 2022-03-09 | Fund Idonial | Composicion para la impresion 3d de farmacos semisolidos |
| WO2021211898A2 (en) * | 2020-04-15 | 2021-10-21 | Aprecia Pharmaceuticals LLC | Multi-component packaged dosage form and method |
| AU2021296908A1 (en) | 2020-06-26 | 2023-02-16 | Aprecia Pharmaceuticals LLC | Rapidly-orodispersible tablets having an interior cavity |
| KR20250008880A (ko) | 2022-04-13 | 2025-01-16 | 아프레시아 파마슈티칼즈 엘엘씨 | 전방향 자기 운동 장치를 이용한 적층 제조를 위한 시스템 및 방법 |
| JP2025526158A (ja) * | 2022-08-18 | 2025-08-07 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 固体薬剤投与形態の製造のためのプロセス |
| WO2024108082A1 (en) | 2022-11-18 | 2024-05-23 | Aprecia Pharmaceuticals LLC | Orodispersive dosage forms containing droxidopa |
| FR3162625A1 (fr) * | 2024-05-30 | 2025-12-05 | Mb Therapeutics | Formulation pharmaceutique imprimable par extrusion, cartouche d’impression renfermant une telle formulation et procédé de préparation d’un médicament la mettant en œuvre |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1548022A (en) | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
| US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
| EP0418596A3 (en) | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
| US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
| DE4200821A1 (de) | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
| US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
| WO1995001782A2 (en) | 1993-07-09 | 1995-01-19 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
| US5490962A (en) * | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
| US5738875A (en) | 1994-10-28 | 1998-04-14 | R.P. Scherer Corporation | Process for preparing solid pharmaceutical dosage forms |
| US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
| WO1998036738A1 (en) * | 1997-02-20 | 1998-08-27 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| FR2766089B1 (fr) | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
| EP1194153B1 (en) | 1999-07-09 | 2004-05-06 | Ortho-McNeil Pharmaceutical, Inc. | Taste masked pharmaceutical liquid formulations |
| DE19940944B4 (de) | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
| AU2001263506A1 (en) * | 2000-05-18 | 2001-11-26 | Massachusetts Institute Of Technology | Encapsulating a toxic core within a non-toxic region in an oral dosage form |
| CA2440069A1 (en) | 2001-03-05 | 2002-09-12 | Ortho-Mcneil Pharmaceutical, Inc. | Taste masked pharmaceutical compositions |
| KR20040002976A (ko) * | 2001-05-18 | 2004-01-07 | 랜박시 래보러터리스 리미티드 | 옥스카르바제핀 제형 |
| US20030099708A1 (en) * | 2001-10-29 | 2003-05-29 | Therics, Inc | Printing or dispensing a suspension such as three-dimensional printing of dosage forms |
| CN1688292A (zh) | 2002-09-04 | 2005-10-26 | 兰贝克赛实验室有限公司 | 掩味剂型及其制造方法 |
| AU2003302881A1 (en) | 2002-12-11 | 2004-06-30 | Ranbaxy Laboratories Limited | Coating composition for taste masking coating and methods for their application and use |
| CN1819819B (zh) | 2003-05-07 | 2011-03-09 | 株式会社三养社 | 用于制备速熔片的高度可塑性颗粒 |
| FR2858556B1 (fr) | 2003-08-06 | 2006-03-10 | Galenix Innovations | Composition pharmaceutique solide dispersible et/ou orodispersible non pelliculee contenant au moins le principe actif metformine, et procede de preparation |
| US20070154550A1 (en) | 2003-08-28 | 2007-07-05 | Potdar Arti | Pharmaceutical composition comprising anticonvulsant with taste mask coating |
| US20060127479A1 (en) | 2004-10-08 | 2006-06-15 | Natrajan Kumaraperumal | Solvent free taste masked pharmaceutical compositions |
| WO2006070406A1 (en) * | 2004-12-29 | 2006-07-06 | J.B. Chemicals & Pharmaceuticals Ltd | Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof |
| US20060182796A1 (en) | 2005-02-03 | 2006-08-17 | Abrika Pharmaceuticals, Inc. | Taste masked pharmaceutical compositions |
| US20070092553A1 (en) | 2005-10-21 | 2007-04-26 | Pfab Lp | Compositions and methods of making rapidly dissolving lonically masked formulations |
| WO2007089247A1 (en) | 2006-01-31 | 2007-08-09 | Teva Pharmaceutical Industries Ltd. | Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| EP2029118A2 (en) * | 2006-01-31 | 2009-03-04 | Teva Pharmaceutical Industries, Inc. | Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| US20070248684A1 (en) * | 2006-01-31 | 2007-10-25 | Sigal Blau | Pharmaceutical formulations of oxcarbazepine and methods for its preparation |
| WO2007121523A1 (en) * | 2006-04-21 | 2007-11-01 | Alphapharm Pty Ltd | Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns |
| WO2008141751A2 (en) * | 2007-05-23 | 2008-11-27 | Ratiopharm Gmbh | Pharmaceutical compositions comprising oxcarbazepine |
| ES2758624T3 (es) | 2009-02-12 | 2020-05-06 | Fuji Chem Ind Co Ltd | Composición de partículas desintegrantes y material de desintegración rápida moldeado por compresión que comprende la misma |
| US20100285130A1 (en) | 2009-05-06 | 2010-11-11 | Monosol Rx, Llc | Coating of complexed actives in film formulations |
| CN102802614A (zh) | 2009-06-04 | 2012-11-28 | 巴斯夫欧洲公司 | 含有被遮味活性成分的口腔崩解剂型 |
| CA2771358A1 (en) | 2009-08-19 | 2011-02-24 | Sascha General | Drug delivery systems (wafer) for pediatric use |
| AR079862A1 (es) | 2010-01-08 | 2012-02-22 | Eurand Inc | Composicion de topiramato con sabor enmascarado, un comprimido desintegrable oralmente que comprende la misma y metodo de preparacion |
| US9381154B2 (en) * | 2011-06-09 | 2016-07-05 | Xerox Corporation | Direct inkjet fabrication of drug delivery devices |
-
2014
- 2014-03-14 CA CA2906107A patent/CA2906107C/en active Active
- 2014-03-14 MX MX2015012136A patent/MX364381B/es active IP Right Grant
- 2014-03-14 WO PCT/US2014/028125 patent/WO2014143935A1/en not_active Ceased
- 2014-03-14 HK HK16101293.4A patent/HK1213472A1/zh unknown
- 2014-03-14 CN CN201480014727.3A patent/CN105050604B/zh active Active
- 2014-03-14 AU AU2014228063A patent/AU2014228063B2/en active Active
- 2014-03-14 EP EP14763545.2A patent/EP2968354B1/en active Active
- 2014-03-14 ES ES14763545T patent/ES2761265T3/es active Active
- 2014-03-14 JP JP2016502709A patent/JP6463333B2/ja active Active
-
2015
- 2015-08-27 US US14/837,493 patent/US9314429B2/en active Active
-
2016
- 2016-02-17 US US15/045,711 patent/US9616018B2/en active Active
-
2017
- 2017-02-21 US US15/437,966 patent/US10028909B2/en active Active
- 2017-05-19 AU AU2017203365A patent/AU2017203365B2/en active Active
-
2018
- 2018-06-22 US US16/015,552 patent/US20180296479A1/en not_active Abandoned
- 2018-09-14 JP JP2018172088A patent/JP2019006812A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014143935A4 (en) | Rapidly dispersible dosage form of oxcarbazepine | |
| JP5911927B2 (ja) | 併用治療のための錠剤 | |
| JP2016514686A5 (enExample) | ||
| KR20190107712A (ko) | 특정 위장 부위에서의 제어 방출의 투여 형태 | |
| KR102046248B1 (ko) | 다공성 위체류층을 포함하는 서방성 제제 및 이의 제조방법 | |
| JP2012144577A5 (enExample) | ||
| JP2015511635A5 (enExample) | ||
| WO2012164578A1 (en) | Compositions and methods for preparing immediate release formulations of nilotinib | |
| HRP20240045T1 (hr) | Tablete s trenutnim oslobađanjem koje sadrže lijek i postupci za proizvodnju tableta | |
| HRP20190550T1 (hr) | Formule i metode proizvodnje formulacija za upotrebu u pražnjenju debelog crijeva | |
| JP5775463B2 (ja) | 溶出安定性製剤 | |
| JP2015120758A5 (enExample) | ||
| JP5347092B2 (ja) | アンドログラフィス抽出物製剤 | |
| RU2662562C2 (ru) | Композиция в форме таблеток, содержащая гидрохлорид цинакалцета | |
| JP2017520619A5 (enExample) | ||
| Purushothaman et al. | Formulation development and Evaluation of immediate and sustained release Bilayer Tablets Containing Amitriptyline HCl and Pregabalin for the treatment of Neuropathic Pain | |
| CN108289849A (zh) | 莫沙必利与雷贝拉唑的复合制剂 | |
| Khemariya et al. | Preparation and in-vitro evaluation of sustained-release matrix tablets of Diltiazem | |
| WO2005082329A2 (en) | Process for the preparation of solid dosage forms of valsartan and hydrochlorthiazide | |
| EP3496719A1 (en) | A multi-class anti-retroviral composition | |
| JP2018530538A5 (enExample) | ||
| JP5910311B2 (ja) | 医薬錠剤およびその製造方法 | |
| JP6392355B2 (ja) | ペレット包含錠剤 | |
| JP6443891B2 (ja) | 徐放性製剤 | |
| Tekade et al. | Orodispersible tablets of lansoprazole: Formulation, characterization and in vitro evaluation |